scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1039669931 |
P356 | DOI | 10.1080/13550280600716604 |
P8608 | Fatcat ID | release_rruplx7n7vbnnf4odnanniiasi |
P698 | PubMed publication ID | 16798673 |
P50 | author | E. Tessa Hedley-Whyte | Q120721373 |
P2093 | author name string | Santosh Kesari | |
Kenneth Williams | |||
Christian Wüthrich | |||
Igor J Koralnik | |||
Rebecca Gelman | |||
Woong-Ki Kim | |||
Umberto De Girolami | |||
Jeffrey T Joseph | |||
Derek Elmeric | |||
P2860 | cites work | Progressive multifocal leukoencephalopathy in a patient treated with natalizumab | Q28255536 |
Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis | Q28255548 | ||
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease | Q28255557 | ||
Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). | Q30787775 | ||
JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. | Q33838943 | ||
Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy | Q34201921 | ||
A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. | Q34328813 | ||
Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy | Q34399011 | ||
Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease | Q34538727 | ||
Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. | Q36890313 | ||
AIDS-associated progressive multifocal leukoencephalopathy (PML): comparison to non-AIDS PML with in situ hybridization and immunohistochemistry | Q43409628 | ||
The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease | Q43639344 | ||
Identification of T lymphocytes in simian immunodeficiency virus encephalitis: distribution of CD8+ T cells in association with central nervous system vessels and virus | Q43899457 | ||
Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. | Q44431490 | ||
Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy | Q45057240 | ||
Atypical progressive multifocal leukoencephalopathy with plasma-cell infiltrates | Q48480551 | ||
Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences | Q48860550 | ||
Patients at Risk | Q53473917 | ||
Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy | Q77336908 | ||
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficits | Q80020017 | ||
P433 | issue | 2 | |
P921 | main subject | progressive multifocal leukoencephalopathy | Q704930 |
lymphocyte | Q715347 | ||
P304 | page(s) | 116-128 | |
P577 | publication date | 2006-04-01 | |
P1433 | published in | Journal of NeuroVirology | Q6295640 |
P1476 | title | Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells | |
P478 | volume | 12 |
Q81408225 | Central nervous system graft-versus-host disease: consider progressive multifocal leukoencephalopathy among the differential diagnoses |
Q44740656 | Collateral neuronal apoptosis in CNS gray matter during an oligodendrocyte-directed CD8(+) T cell attack. |
Q33547027 | Demyelinating disorders |
Q33945721 | Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation |
Q37697448 | Differences in T cell cytotoxicity and cell death mechanisms between progressive multifocal leukoencephalopathy, herpes simplex virus encephalitis and cytomegalovirus encephalitis. |
Q43115882 | Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy |
Q35785136 | Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy |
Q37088626 | Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy |
Q33834119 | Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons |
Q21285083 | Human polyomavirus reactivation: disease pathogenesis and treatment approaches |
Q40764534 | Immune suppression of JC virus gene expression is mediated by SRSF1. |
Q37678580 | Immune surveillance and response to JC virus infection and PML. |
Q38367755 | Immunology of progressive multifocal leukoencephalopathy. |
Q37198798 | Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis |
Q34545686 | Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy |
Q38379787 | JC Virus Infects Neurons and Glial Cells in the Hippocampus |
Q34120183 | JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy |
Q35864067 | Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System |
Q41361912 | MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS. |
Q40792696 | Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant |
Q24619923 | Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain |
Q35736438 | Natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a postmortem study |
Q26822247 | New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy |
Q30613846 | PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section |
Q37828002 | Pathogenesis of progressive multifocal leukoencephalopathy--revisited |
Q30235523 | Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency. |
Q38577593 | Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS). |
Q33893285 | Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis |
Q34529503 | Pur-Alpha Induces JCV Gene Expression and Viral Replication by Suppressing SRSF1 in Glial Cells |
Q37951338 | Role of p53 in neurodegenerative diseases |
Q26859307 | The importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathy |
Q41953075 | The roles of CD8 central and effector memory T-cell subsets in allograft rejection. |
Search more.